Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2019

View Archived Issues

'CYRI, prevent that infection!'

Finding MDS' iron fist

New platform optimizes genome-editing enzyme activity

Ambrx announces initiation of phase I study of a long-acting relaxin

Novartis publishes first-in-human data for LYS-228

AMG-424 demonstrates promising activity in preclinical models of multiple myeloma

Teplizumab delays progression to clinical type 1 diabetes in relatives at risk

SAD study data on the anti-phospho-tau antibody JNJ-63733657 in healthy subjects presented

SHANK3-mutant macaque with altered connectivity and behavior as a model of autism spectrum disorder

PBD-C06: development candidate for immunotherapy against Alzheimer's disease

Druggability Technologies begins phase II trial of DRGT-119 for chronic anal fissure

Sichuan Kelun-Biotech Biopharmaceutical describes bile acid receptor agonists

mTORC1/mTORC2 inhibitor MTI-31 shows promise for treating lung cancer

Merck & Co. identifies PI3Kdelta inhibitors

Chiesi Farmaceutici divulges Rho kinase inhibitors

Boehringer Ingelheim patents SOS1 inhibitors

STING is required to restrict MCMV dissemination to lymph nodes

Bristol-Myers Squibb presents Toll-like receptor antagonists

Skyhawk and Genentech to discover and develop small-molecule RNA splicing modifiers

Affibody completes 12-week interim analysis of phase II psoriasis study of ABY-035

MDA funding supports development of small-molecule drugs to increase sarcospan expression for DMD

Mallinckrodt discontinues phase IIb study of Acthar gel in ALS

Researchers in search of small-molecule NAMPT activators for Alzheimer's disease

FDA clears investigator-initiated phase II trial of GKT-831 for IPF

Cyclica and University of Toronto enter EGFR inhibitor collaboration

FDA approves Recarbrio for complicated urinary tract and intra-abdominal infections

Invio cuts select early R&D programs to focus on HPV-related diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...